The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control
Abstract
Background After ingestion of phosphatidylcholine, l-carnitine or betaine, trimethylamine-N-oxide (TMAO) is formed by gut microbiota and liver enzymes. Elevated TMAO plasma levels were associated with increased cardiovascular risk and other diseases. Also betaine and choline itself were recently associated with increased cardiovascular risk.Methods A newly developed LC-HRMS method was applied to measure the plasma concentrations of TMAO, betaine and choline in a cohort of 339 patients undergoing coronary angiography for the evaluation of suspected coronary artery disease.Results Betaine concentrations in males were significantly higher than in females (42.0 vs. 35.9 μmol/L; p < 0.001). Plasma concentrations of TMAO but not of betaine or choline were higher in patients with diabetes compared to euglycemic patients (2.39 vs. 0.980 μmol/L; p = 0.001) as well as in patients with metabolic syndrome as compared to patients without metabolic syndrome (2.37 vs. 1.43 μmol/L; p = 0.002). Plasma concentrations of TMAO or choline increased significantly with decreasing renal function (Spearman's rho: -0.281; p < 0.001). However, plasma levels of TMAO or betaine were associated with neither a history of myocardial infarction nor the angiographically assessed presence of coronary heart disease, nor incident cardiovascular events during 8 years of follow-up. Plasma levels of choline were significantly lower in patients with a history of acute myocardial infarction as compared to those without such history (10.0 vs. 10.8 μmol/L; p = 0.045).Conclusions Plasma levels of TMAO are confounded by impaired kidney function and poor metabolic control but are not associated with the history, presence or incidence of symptoms or events of coronary heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mueller et al., (2015) [47] did an 8 years follow-up study trying to relate plasma TMAO, betaine or choline levels with cardiovascular disease (CVD), but the results showed that the levels were confounded by impaired kidney function or poor metabolic control and they were not associated with presence, incidence or events of coronary heart disease.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [47]
In the citing paper
“Differences in characteristics and disease status of participants across studies might affect TMAO levels14, 27, 28 and therefore partly explain such inconsistency.”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [14]
In the citing paper
“Also, another 3 studies did not show a significantly elevated RR when TMAO was analyzed as a continuous variable in model.10, 14, 17”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [14]
In the citing paper
“One study14 introduced a newly developed method for the measurement of TMAO, and their IQRs of TMAO were lower than other studies, so that we calculated a RR without data from the study. Results of the analysis showed a similar pooled adjusted RR per 1‐μmol/L increment in TMAO of 1.02 (1.01, 1.04).”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [14]
In the citing paper
“In a cohort of 339 patients who underwent coronary angiography, plasma concentrations of TMAO or choline were significantly increased with decreasing renal function, but TMAO concentrations were not associated with incidence or symptoms of coronary heart disease.”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [85]
In the citing paper
“In a cohort of 339 patients who underwent coronary angiography, plasma concentrations of TMAO or choline were significantly increased with decreasing renal function, but TMAO concentrations were not associated with incidence or symptoms of coronary heart disease.”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [85]
In the citing paper
“The study concluded that plasma concentrations of TMAO were confounded by impaired kidney function because it was increased with declining GFR (85).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [85]
In the citing paper
“The plasma levels of TMAO or betaine were not found to be associated with a history of myocardial infarction, the angiographically-assessed presence of coronary heart disease, or the incident cardiovascular events during 8 years of follow-up.”
From Trimethylamine N-oxide: the good, the bad and the unknown. (2016) · cites this paper as [35]
In the citing paper
“Mueller et al. measured plasma concentrations of TMAO, betaine and choline in a cohort of 339 patients undergoing coronary angiography and noted that plasma concentrations of TMAO were higher in diabetics compared to euglycemic patients [35].”
From Trimethylamine N-oxide: the good, the bad and the unknown. (2016) · cites this paper as [35]
In the citing paper
“TMAO and choline levels increase with decreasing renal function [35].”
From Trimethylamine N-oxide: the good, the bad and the unknown. (2016) · cites this paper as [35]
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Matuszewski, B. K., Constanzer, M. L., & Chavez-Eng, C. M. (2003) · Analytical Chemistry · doi:10.1021/ac020361s · Cited by 5,426
Heart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,264
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.1 · Cited by 4,326
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Research works printed but not linked: 1
- Kidney disease, 2012, Improving global outcomes (kdigo) acute kidney injury work group. Kdigo clinical practice guideline for acute kidney injury, Kidney Inter., 2, 1
Cited by
Sorted by citations
Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631
“, (2015) [47] did an 8 years follow-up study trying to relate plasma TMAO, betaine or choline levels with cardiovascular disease (CVD), but the results showed that the levels were confounded by impaired kidney function or poor metabolic control and they were not associated with presence, incidence or events of coronar…”
BackgroundSchiattarella, G. G., Sannino, A., Toscano, E., Giugliano, G., Gargiulo, G., Franzone, A., Trimarco, B., Esposito, G., & Perrino, C. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx342 · Cited by 563
Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M., & Qi, L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004947 · Cited by 544
Trimethylamine N-oxide: the good, the bad and the unknown.
Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504
Li, X. S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw582 · Cited by 479
Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease
Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475
Zoccali, C., Vanholder, R. C., Massy, Z. A., Ortíz, A., Sarafidis, P. A., Dekker, F. W., Fliser, D., Fouque, D. P., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 464
Microbial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440
Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction
Chen, S., Henderson, A., Petriello, M. C., Romano, K. A., Gearing, M., Miao, J., Schell, M., Sandoval-Espinola, W. J., Tao, J., Sha, B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.021 · Cited by 427
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health
Vernocchi, P., Del Chierico, F., & Putignani, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01144 · Cited by 426
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Verhaar, B. J. H., Prodan, A., Nieuwdorp, M., & Muller, M. (2020) · Nutrients · doi:10.3390/nu12102982 · Cited by 425
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 360
Dietary Choline Intake: Current State of Knowledge Across the Life Cycle
Wiedeman, A. M., Barr, S. I., Green, T., Xu, Z., Innis, S. M., & Kitts, D. D. (2018) · Nutrients · doi:10.3390/nu10101513 · Cited by 328
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
Randrianarisoa, E., Lehn-Stefan, A., Wang, X., Hoene, M., Peter, A., Heinzmann, S. S., Zhao, X., Königsrainer, I., Königsrainer, A., Balletshofer, B., et al. (2016) · Scientific Reports · doi:10.1038/srep26745 · Cited by 296
Senthong, V., Wang, Z., Li, X. S., Fan, Y., Wu, Y., Wilson Tang, W. H., & Hazen, S. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002816 · Cited by 270
Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Barrea, L., Annunziata, G., Muscogiuri, G., Somma, C. D., Laudisio, D., Maisto, M., de Alteriis, G., Tenore, G. C., Colao, A., & Savastano, S. (2018) · Nutrients · doi:10.3390/nu10121971 · Cited by 266
Liu, Y., & Dai, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/4634172 · Cited by 235
Trimethylamine N-oxide (TMAO) in human health
Gątarek, P., & Kałużna‐Czaplińska, J. (2020) · EXCLI journal · doi:10.17179/excli2020-3239 · Cited by 235
Trimethylamine- N -Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?
Cho, C. E., & Caudill, M. A. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.10.005 · Cited by 220
Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis
Li, Z., Wu, Z., Yan, J., Liu, H., Liu, Q., Deng, Y., Ou, C., & Chen, M. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0091-y · Cited by 221
Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes
Shan, Z., Sun, T., Huang, H., Chen, S., Chen, L., Luo, C., Yang, W., Yang, X., Yao, P., Cheng, J., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.157107 · Cited by 210
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Canyelles, M., Borràs, C., Rotllán, N., Tondo, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031940 · Cited by 218
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Brial, F., Lay, A. L., Dumas, M., & Gauguier, D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2901-1 · Cited by 201
Rohrmann, S., Linseisen, J., Allenspach, M., von Eckardstein, A., & Müller, D. (2016) · The Journal of Nutrition · doi:10.3945/jn.115.220103 · Cited by 197
Self-citationCanyelles, M., Tondo, M., Cedó, L., Farràs, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103228 · Cited by 197
Causality of small and large intestinal microbiota in weight regulation and insulin resistance
Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.002 · Cited by 188
Zhuang, R., Ge, X., Han, L., Yu, P., Gong, X., Meng, Q., Zhang, Y., Fan, H., Zheng, L., Liu, Z., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12843 · Cited by 188
Meyer, K. A., Benton, T. Z., Bennett, B. J., Jacobs, D. R., Lloyd‐Jones, D. M., Gross, M. D., Carr, J. J., Gordon‐Larsen, P., & Zeisel, S. H. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003970 · Cited by 168
Bekhit, A. E. A., Giteru, S. G., Holman, B. W. B., & Hopkins, D. L. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12764 · Cited by 170
Urea and chronic kidney disease: the comeback of the century? (in uraemia research)
Vanholder, R. C., Gryp, T., & Glorieux, G. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx039 · Cited by 178
A Multi-omic Association Study of Trimethylamine N-Oxide
Manor, O., Zubair, N., Conomos, M. P., Xu, X., Rohwer, J. E., Krafft, C. E., Lovejoy, J. C., & Magis, A. T. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.096 · Cited by 165
Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease
Roncal, C., Martínez-Aguilar, E., Orbe, J., Ravassa, S., Fernández‐Montero, A., Saenz‐Pipaon, G., Ugarte, A., de Mendoza, A. E., Rodríguez, J. A., Fernandez-Alonso, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52082-z · Cited by 165
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease
Ascher, S., & Reinhardt, C. (2017) · European Journal of Immunology · doi:10.1002/eji.201646879 · Cited by 154
Djekic, D., Shi, L. S., Brolin, H., Carlsson, F., Särnqvist, C., Savolainen, O. I., Cao, Y., Bäckhed, F., Tremaroli, V., Landberg, R., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016518 · Cited by 165
Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria
Makrecka‐Kuka, M., Volska, K., Antone, U., Vilšķe̅rsts, R., Grı̄nberga, S., Bandere, D., Liepinsh, E., & Dambrova, M. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.12.017 · Cited by 143
Trimethylamine N -oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
Nowiński, A., & Ufnal, M. (2017) · Nutrition · doi:10.1016/j.nut.2017.08.001 · Cited by 132
Walford, G. A., Ma, Y., Clish, C. B., Florez, J. C., Wang, T. J., & Gerszten, R. E. (2016) · Diabetes · doi:10.2337/db15-1063 · Cited by 128
Tomlinson, J. A. P., & Wheeler, D. C. (2017) · Kidney International · doi:10.1016/j.kint.2017.03.053 · Cited by 121
Winther, S. A., Oellgaard, J., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H., Hansen, T. W., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0048 · Cited by 111
Koay, Y. C., Chen, Y., Wali, J. A., Luk, A. W. S., Li, M., Doma, H., Reimark, R., Zaldivia, M. T. K., Habtom, H. T., Franks, A. E., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa094 · Cited by 113
Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year
Kühn, T., Rohrmann, S., Sookthai, D., Johnson, T., Katzke, V., Kaaks, R., von Eckardstein, A., & Müller, D. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0374 · Cited by 110
Exploratory metabolomics of metabolic syndrome: A status report
Lent-Schochet, D., McLaughlin, M. J., Ramakrishnan, N., & Jialal, I. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i1.23 · Cited by 108
Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites
Croci, S., D'Apolito, L. I., Gasperi, V., Catani, M. V., & Savini, I. (2021) · Nutrients · doi:10.3390/nu13051389 · Cited by 111
Dong, C., Yang, Y., Wang, Y., Hu, X., Wang, Q., Gao, F., Sun, S., Liu, Q., Li, L., Liu, J., et al. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.06.008 · Cited by 103
Gut microbiota in cardiovascular disease and heart failure
Kitai, T., & Tang, W. H. W. (2018) · Clinical Science · doi:10.1042/cs20171090 · Cited by 106
Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology
Samodelov, S. L., Kullak-Ublick, G. A., Gai, Z., & Visentin, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217890 · Cited by 97
Lee, Y., Nemet, I., Wang, Z., Lai, H. T. M., Otto, M. C. D. O., Lemaître, R. N., Fretts, A. M., Sotoodehnia, N., Budoff, M. J., DiDonato, J. A., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020646 · Cited by 95
Gut Microbiota and Atherosclerosis
Li, D. Y., & Tang, W. H. W. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0675-9 · Cited by 90
Tang, W. H. W., Li, X. S., Wu, Y., Wang, Z., Khaw, K., Wareham, N. J., Nieuwdorp, M., Boekholdt, S. M., & Hazen, S. L. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.01.020 · Cited by 92
Zeng, Y., Guo, M., Xia, F., Teng, F., Tan, X., Li, X., Wang, M., Long, Y., & Xu, Y. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab010 · Cited by 94
Kumari, S., Goyal, V., Kumaran, S. S., Dwivedi, S. N., Srivastava, A. K., & Jagannathan, N. R. (2020) · Neurological Sciences · doi:10.1007/s10072-019-04143-4 · Cited by 84
Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke
Rexidamu, M., Li, H., Jin, H., & Huang, J. (2019) · Bioscience Reports · doi:10.1042/bsr20190515 · Cited by 84
Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality?
Morán‐Ramos, S., López-Contreras, B. E., & Canizales‐Quinteros, S. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.003 · Cited by 91
Wang, M., Wang, Z., Lee, Y., Lai, H. T. M., Otto, M. C. D. O., Lemaître, R. N., Fretts, A. M., Sotoodehnia, N., Budoff, M. J., DiDonato, J. A., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316533 · Cited by 85
Wang, M., Li, X. S., Wang, Z., Otto, M. C. D. O., Lemaître, R. N., Fretts, A. M., Sotoodehnia, N., Budoff, M. J., Nemet, I., DiDonato, J. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad089 · Cited by 84
Yu, D., Shu, X., Rivera, E. S., Zhang, X., Cai, Q., Calcutt, M. W., Xiang, Y., Li, H., Gao, Y., Wang, T. J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010606 · Cited by 81
Gao, J., Yan, K.-T., Wang, J.-X., Dou, J., Wang, J., Ren, M., Ma, J., Zhang, X., & Liu, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-59235-5 · Cited by 76
Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus
Li, P., Zhong, C., Li, S., Sun, T., Huang, H., Chen, X., Zhu, Y., Hu, X., Peng, X., Zhang, X., et al. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy116 · Cited by 78
Ottiger, M., Nickler, M., Steuer, C., Bernasconi, L., Huber, A., Christ‐Crain, M., Henzen, C., Hoess, C., Thomann, R., Zimmerli, W., et al. (2017) · Nutrition · doi:10.1016/j.nut.2017.07.001 · Cited by 75
Trimethylamine N -oxide: heart of the microbiota–CVD nexus?
Naghipour, S., Cox, A. J., Peart, J. N., Toit, E. F. D., & Headrick, J. P. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000177 · Cited by 77
Awwad, H. M., Geisel, J., & Obeid, R. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.10.017 · Cited by 73
Farhangi, M. A., Vajdi, M., & Asghari-Jafarabadi, M. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00592-2 · Cited by 72
Molecular interactions between the intestinal microbiota and the host
Hertli, S., & Zimmermann, P. (2022) · Molecular Microbiology · doi:10.1111/mmi.14905 · Cited by 82
Pancreatic and mucosal enzymes in choline phospholipid digestion
Nilsson, Å., & Duan, R. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00320.2018 · Cited by 70
Schneider, C., Okun, J. G., Schwarz, K. V., Hauke, J., Zorn, M., Nürnberg, C., Ungerer, M. N., Ringleb, P. A., & Mundiyanapurath, S. (2020) · European Journal of Neurology · doi:10.1111/ene.14253 · Cited by 64
Delgado, J., Ansorena, D., HECKE, T. V., Astiasarán, I., SMET, S. D., & Estévez, M. (2020) · Meat Science · doi:10.1016/j.meatsci.2020.108278 · Cited by 67
Tousoulis, D., Guzik, T. J., Padró, T., Duncker, D. J., Luca, G. D., Eringa, E. C., Vavlukis, M., Antonopoulos, A. S., Katsimichas, T., Cenko, E., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac057 · Cited by 67
Balancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide
Loo, R. L., Chan, Q. M., Nicholson, J. K., & Holmes, E. C. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00851 · Cited by 63
The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison
Evans, M., Dai, L., Avesani, C. M., Kublickiene, K. R., & Stenvinkel, P. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad095 · Cited by 68
Gut microbiota in kidney disease and hypertension
Antza, C., Stabouli, S., & Kotsis, V. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.028 · Cited by 61
Tacconi, E., Palma, G., Biase, D. D., Luciano, A., Barbieri, M., de Nigris, F., & Bruzzese, F. (2023) · Nutrients · doi:10.3390/nu15030563 · Cited by 62
Sowah, S. A., Milanese, A., Schübel, R., Wirbel, J., Kartal, E., Johnson, T., Hirche, F., Grafetstätter, M., Nonnenmacher, T., Kirsten, R., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01030-0 · Cited by 61
Yang, J. J., Shu, X., Herrington, D. M., Moore, S. C., Meyer, K. A., Ose, J., Menni, C., Palmer, N. D., Eliassen, A. H., Harada, S., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa430 · Cited by 54
Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI
Matsuzawa, Y., Nakahashi, H., Konishi, M., Sato, R., Kawashima, C., Kikuchi, S., Akiyama, E., Iwahashi, N., Maejima, N., Okada, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48246-6 · Cited by 54
Samulak, J. J., Sawicka, A. K., Hartmane, D., Grı̄nberga, S., Pugovičs, O., Łysiak−Szydłowska, W., & Olek, R. A. (2018) · Annals of Nutrition and Metabolism · doi:10.1159/000495037 · Cited by 54
Association between Plasma Trimethylamine N-Oxide Levels and Type 2 Diabetes: A Case Control Study
Kalagi, N. A., Thota, R. N., Stojanovski, E., Alburikan, K. A., & Garg, M. L. (2022) · Nutrients · doi:10.3390/nu14102093 · Cited by 52
El‐Deeb, O. S., Atef, M. M., & Hafez, Y. M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28707 · Cited by 52
Gut microbiota and their metabolites in cardiovascular disease
Jansen, V. L. B. I., Gerdes, V. E. A., Middeldorp, S., & van Mens, T. E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101492 · Cited by 50
Lemos, B. S., Vera, I., Malysheva, O., Caudill, M. A., & Fernández, M. L. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1466213 · Cited by 46
Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke
Zhang, J., Wang, L., Cai, J., Lei, A., Liu, C., Lin, R., Li, J., & Fu, Y. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577526 · Cited by 45
Reiner, M. F., Müller, D., Gobbato, S., Stalder, O., Limacher, A., Bonetti, N. R., Pasterk, L., Méan, M., Rodondi, N., Aujesky, D., et al. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.12.011 · Cited by 44
Zheng, L., Zheng, J., Xie, Y., Zhao, L., Guo, X., Sun, G., Sun, Z., Xing, F., & Sun, Y. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.11.010 · Cited by 42
Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation
Iglesias‐Carres, L., Hughes, M. D., Steele, C. N., Ponder, M. A., Davy, K. P., & Neilson, A. P. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108600 · Cited by 43
Krueger, E. S., Lloyd, T. S., & Tessem, J. S. (2021) · Nutrients · doi:10.3390/nu13082873 · Cited by 41
Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk
Koopen, A. M., Groen, A. K., & Nieuwdorp, M. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000357 · Cited by 41
Ringel, C., Dittrich, J., Gaudl, A., Schellong, P., Beuchel, C. F., Baber, R., Beutner, F., Teren, A., Engel, C., Wirkner, K., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.026 · Cited by 43
Xiong, X., Zhou, J. W., Fu, Q., Xu, X., Wei, S., Yang, S., & Chen, B. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01673-3 · Cited by 41
Onyszkiewicz, M., Jaworska, K., & Ufnal, M. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219900898 · Cited by 39
Trimethylamine-N-oxide and its biological variations in vegetarians.
Obeid, R., Awwad, H. M., Keller, M., & Geisel, J. (2017) · European Journal of Nutrition · doi:10.1007/s00394-016-1295-9 · Cited by 38
TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts
Stefania, K., Ashok, K. K., Varghese, G., Katarina, P., & Demirel, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-58084-w · Cited by 42
TMAO and diabetes: from the gut feeling to the heart of the problem
Jaworska, K., Kuś, M., & Ufnal, M. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00377-8 · Cited by 43
Andraos, S., Jones, B., Lange, K., Clifford, S. A., Thorstensen, E. B., Kerr, J. A., Wake, M. A., Saffery, R., Burgner, D. P., & O'Sullivan, J. M. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa179 · Cited by 40
Noonan, J. E., Bobik, A., & Peter, K. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15356 · Cited by 37
Dai, L., Massy, Z. A., Stenvinkel, P., Chesnaye, N. C., Larabi, I. A., Alvarez, J., Caskey, F. J., Torino, C., Porto, G., Szymczak, M., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac278 · Cited by 38
Huang, J. Y., Luu, H. N., Butler, L. M., Midttun, Ø., Ulvik, A., Wang, R., Jin, A., Gao, Y., Tan, Y., Ueland, P. M., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32994 · Cited by 36
Bordoni, L., Samulak, J. J., Sawicka, A. K., Pelikant‐Małecka, I., Radulska, A., Lewicki, Ł., Kalinowski, L., Gabbianelli, R., & Olek, R. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-75633-1 · Cited by 37
The gut microbiota in thrombosis
Khuu, M. P., Paeslack, N., Dremova, O., Benakis, C., Kiouptsi, K., & Reinhardt, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01070-6 · Cited by 36
Winther, S. A., Oellgaard, J., Hansen, T. W., von Scholten, B. J., Reinhard, H., Ahluwalia, T. S., Wang, Z., Gæde, P., Parving, H., Hazen, S. L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244402 · Cited by 36
Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk
Meyer, K. A., & Bennett, B. J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0791-x · Cited by 35
Querio, G., Antoniotti, S., Levi, R. C., & Gallo, M. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123045 · Cited by 33
Metadata
- Authors
- Mueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank, A., Drexel, H., & von Eckardstein, A.
- Affiliations
- University of Zurich (CH)
- Landeskrankenhaus Feldkirch (AT)
- ORCID
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 243
- Issue
- 2
- Pages
- 638-644
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W1751395982
- Cited by
- 217
- References
- 46
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 18 · 2023: 21 · 2022: 30 · 2021: 19 · 2020: 36 · 2019: 18 · 2018: 20 · 2017: 20 · 2016: 18 · 2015: 1
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- trimethylamine N-oxide, betaine, choline, plasma biomarkers, renal function, renal dysfunction, metabolic control, diabetes mellitus, metabolic syndrome, coronary artery disease, myocardial infarction, cardiovascular risk, gut microbiota
- MeSH terms
- Aged, Betaine, Blood Glucose, Choline, Chromatography, Liquid, Coronary Disease, Diabetes Mellitus, Female, Glomerular Filtration Rate, Humans, Kidney, Male, Methylamines, Middle Aged, Predictive Value of Tests, Prognosis, Time Factors, Reproducibility of Results, Biomarkers, Coronary Angiography, Spectrometry, Mass, Electrospray Ionization, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
